Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Jewish General Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Quebec Clinical Research Organization in Cancer
Genome Quebec
Information provided by (Responsible Party):
Mark Basik, Jewish General Hospital
ClinicalTrials.gov Identifier:
NCT01276899
First received: January 12, 2011
Last updated: November 28, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given